[Risk of fungal disease during systemic diseases]

Presse Med. 2009 Feb;38(2):260-73. doi: 10.1016/j.lpm.2008.11.006. Epub 2008 Dec 25.
[Article in French]

Abstract

Invasive fungal diseases are sparse but responsible for a high mortality. During systemic diseases, they are less common than bacterial infection but are probably underdiagnosed. Diagnosis of invasive fungal disease might be difficult: clinical signs may mimic systemic diseases, uninvasive diagnostic tools have not been evaluated in this situation and invasive exploration (histology) is rarely done. Guidelines for invasive fungal disease curative treatment are available but preventive strategies need to be evaluated in the population of patients with systemic diseases.

Publication types

  • English Abstract

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Aspergillosis / epidemiology
  • Coccidioidomycosis / epidemiology
  • Cryptococcosis / epidemiology
  • Histoplasmosis / epidemiology
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Lupus Erythematosus, Systemic / complications
  • Mushroom Poisoning / complications
  • Mushroom Poisoning / drug therapy
  • Mycoses / epidemiology*
  • Mycoses / mortality
  • Mycoses / prevention & control
  • Risk Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents